Companies / CytomX Therapeutics, Inc. / Activity
Activity — CytomX Therapeutics, Inc.
4 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | Ogden Christopher Executive | Sell | Common Stock | $124.1K | -19K -6.11% | 296,948 0.14% of shares | medium |
| Mar 17, 2026 | Chu Yu-Waye Executive | Sell | Common Stock | $136.7K | -21K -10.10% | 189,446 0.09% of shares | medium |
| Mar 17, 2026 | Belvin Marcia Executive | Sell | Common Stock | $202.3K | -31K -9.48% | 300,760 0.14% of shares | medium |
| Mar 17, 2026 | McCarthy Sean A. CEO | Sell | Common Stock | $764.1K | -119K -9.93% | 1,078,922 0.50% of shares | medium |